4//SEC Filing
Angel Matthew 4
Accession 0001140361-22-028096
CIK 0000748592other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 8:01 PM ET
Size
5.5 KB
Accession
0001140361-22-028096
Insider Transaction Report
Form 4
Angel Matthew
DirectorInterim President and CEO
Transactions
- Award
Stock Option (right to buy)
2022-08-01+2,487,003→ 2,487,003 totalExercise: $0.49Exp: 2032-08-01→ Common Stock, par value $0.005 per share (2,487,003 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable over four years (subject to continued service), with 2/48th of the shares vesting on the grant date and the remaining shares vesting in 46 substantially equal monthly installments thereafter.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001931356
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 8:01 PM ET
- Size
- 5.5 KB